PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 11, 2026Advances in respiratory medicine0 citationsOpen Access

Differences in Causes, Severity, and Treatment Outcomes Between Women and Men with Chronic Cough

AMAleksandra MarchwińskaKMKatarzyna MazurekKBK Białek-Gosk

Key Points

  • The aim is to compare the causes and treatment outcomes of chronic cough in women and men.
  • Retrospective analysis of patients diagnosed with chronic cough in a cough clinic from 2017 to 2021.
  • Assessment of treatment response using a 100 mm visual analogue scale (VAS).
  • Cohort included 231 patients: 164 women and 67 men.
  • Upper airway cough syndrome (UACS) more frequently diagnosed in men (75%) than women (53%).
  • Obstructive sleep apnea (OSA) diagnosed more in men (21%) vs. women (6%).
  • Cough severity decreased for both genders, with median VAS scores dropping from 55 to 40 mm in women and from 69 to 39 mm in men.
  • Treatment effectiveness was higher in men, with median VAS reduction of 32 mm compared to 17.5 mm in women.

Abstract

A chronic cough, defined as a cough persisting for more than eight weeks in adults, is a common clinical problem with a significant impact on patients’ quality of life. This study compares the etiological spectrum and treatment effectiveness of chronic cough in male and female patients. A retrospective analysis was conducted on a cohort of patients diagnosed in the cough clinic between 2017 and 2021. The response to treatment was assessed based on the reduction in cough severity measured using a 100 mm visual analogue scale (VAS). This study included 231 patients: 164 women (70.9%) and 67 men (29.1%). The median duration of cough was 48 months (IQR 24–120). There were no gender differences in age, BMI, smoking history, cough duration, or severity at the initial visit. Upper airway cough syndrome (UACS) and obstructive sleep apnea (OSA) were diagnosed more frequently in men than in women (UACS: 75% vs. 53%, p = 0.002; OSA: 21% vs. 6%, p = 0.001). Cough severity significantly decreased in both groups; the median VAS score dropped from 55 to 40 mm in women (p < 0.0001) and from 69 to 39 mm in men (p = 0.009). The effectiveness of chronic cough treatment, measured by the median reduction in VAS score, was greater in men than in women (32 mm vs. 17.5 mm, p = 0.006). These gender-specific differences in cough etiology and treatment response suggest that a “one-size-fits-all” approach may be inadequate.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Marchwińska et al. (2026) studied this question.

synapsesocial.com/papers/698c1d1d267fb587c655f9ffhttps://doi.org/10.3390/arm94010010
Ask AI
Helpful
Bookmark
Share
View Full Paper